Back to Trades
Accardi Mario Alberto
Chief Executive OfficerDirectorCIK 0002074392
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 8
- Companies
- 1
- Active
- 2025–2026
Accardi Mario Alberto, Chief Executive Officer, Director, has filed 10 reports across 1 company, totaling $19.7M in disclosed volume. Sales ($1.2M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jun 24 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Other | $0 |
| May 18 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Other | $0 |
| Feb 3 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | Chief Executive Officer, Director | Grant | $0 |
| Dec 9 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $288.3K |
| Dec 8 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $300.0K |
| Oct 27 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $200.0K |
| Sep 16 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $174.8K |
| Sep 11 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $140.0K |
| Aug 1 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Other | $0 |
| Jul 30 | CNTA Centessa Pharmaceuticals plc | Accardi Mario Alberto | President, Orexin Program | Sell | $126.8K |
10 filings